Pharmaceutical Grade Melatonin Products - Global Top Players Market Share and Ranking 2025- YH Research

Home > Reports >Pharma & Healthcare > Pharmaceutical Grade Melatonin Products - Global Top Players Market Share and Ranking 2025

Pharmaceutical Grade Melatonin Products - Global Top Players Market Share and Ranking 2025

Publication Date: 2025-12-12
Report Id: 2862806
Industry: Pharma & Healthcare
Report Page: 148
Chart: 145

PDF Download

Publication Date: 2025-12-12
Report Id: 2862806
Industry: Pharma & Healthcare
Report Page: 148
Chart: 145

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Pharmaceutical Grade Melatonin Products Definition
1.2 Global Pharmaceutical Grade Melatonin Products Market Size and Forecast
1.2.1 By Consumption Value, Global Pharmaceutical Grade Melatonin Products Market Size, 2020-2031
1.2.2 By Sales Quantity, Global Pharmaceutical Grade Melatonin Products Market Size, 2020-2031
1.2.3 Global Pharmaceutical Grade Melatonin Products Average Selling Price (ASP), 2020-2031
1.3 China Pharmaceutical Grade Melatonin Products Market Size and Forecast
1.3.1 By Consumption Value, China Pharmaceutical Grade Melatonin Products Market Size, 2020-2031
1.3.2 By Sales Quantity, China Pharmaceutical Grade Melatonin Products Market Size, 2020-2031
1.3.3 China Pharmaceutical Grade Melatonin Products Average Selling Price (ASP), 2020-2031
1.4 Share of China Pharmaceutical Grade Melatonin Products Market with Respect to the Global Market
1.4.1 By Consumption Value, China Pharmaceutical Grade Melatonin Products Market Share in Global, 2020-2031
1.4.2 By Sales Quantity, China Pharmaceutical Grade Melatonin Products Market Share in Global, 2020-2031
1.4.3 Pharmaceutical Grade Melatonin Products Market Size: China VS Global, 2020-2031
1.5 Pharmaceutical Grade Melatonin Products Market Dynamics
1.5.1 Pharmaceutical Grade Melatonin Products Market Drivers
1.5.2 Pharmaceutical Grade Melatonin Products Market Restraints
1.5.3 Pharmaceutical Grade Melatonin Products Industry Trends
1.5.4 Pharmaceutical Grade Melatonin Products Industry Policy

2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Pharmaceutical Grade Melatonin Products, Global Market Share by Company, 2020-2025
2.2 By Sales Quantity of Pharmaceutical Grade Melatonin Products, Global Market Share by Company, 2020-2025
2.3 Pharmaceutical Grade Melatonin Products Average Selling Price (ASP) by Company, 2020-2025
2.4 Global Pharmaceutical Grade Melatonin Products Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Pharmaceutical Grade Melatonin Products Concentration Ratio
2.6 Global Pharmaceutical Grade Melatonin Products Mergers & Acquisitions, Expansion Plans
2.7 Global Pharmaceutical Grade Melatonin Products Manufacturers Product Type
2.8 Head Office and Pharmaceutical Grade Melatonin Products Production Site of Key Manufacturer
2.9 Pharmaceutical Grade Melatonin Products Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share
3.1 By Revenue of Pharmaceutical Grade Melatonin Products, China Market Share by Company, 2020-2025
3.2 By Sales Quantity of Pharmaceutical Grade Melatonin Products, China Market Share by Company, 2020-2025
3.3 China Pharmaceutical Grade Melatonin Products Pharmaceutical Grade Melatonin Products Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions
4.1 Global Pharmaceutical Grade Melatonin Products Capacity, Output and Capacity Utilization, 2020-2031
4.2 Global Pharmaceutical Grade Melatonin Products Capacity by Region
4.3 Global Pharmaceutical Grade Melatonin Products Production & Forecast by Region, 2020 VS 2024 VS 2031
4.4 Global Pharmaceutical Grade Melatonin Products Production by Region, 2020-2031
4.5 Global Pharmaceutical Grade Melatonin Products Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Pharmaceutical Grade Melatonin Products Industry Chain
5.2 Pharmaceutical Grade Melatonin Products Upstream Analysis
5.2.1 Pharmaceutical Grade Melatonin Products Core Raw Materials
5.2.2 Main Manufacturers of Pharmaceutical Grade Melatonin Products Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Pharmaceutical Grade Melatonin Products Production Mode
5.6 Pharmaceutical Grade Melatonin Products Procurement Model
5.7 Pharmaceutical Grade Melatonin Products Industry Sales Model and Sales Channels
5.7.1 Pharmaceutical Grade Melatonin Products Sales Model
5.7.2 Pharmaceutical Grade Melatonin Products Typical Distributors

6 Sights by Type
6.1 Pharmaceutical Grade Melatonin Products Classification by Type
6.1.1 Tablets
6.1.2 Oral Solution
6.2 by Type, Global Pharmaceutical Grade Melatonin Products Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Pharmaceutical Grade Melatonin Products Consumption Value, 2020-2031
6.4 by Type, Global Pharmaceutical Grade Melatonin Products Sales Quantity, 2020-2031
6.5 by Type, Global Pharmaceutical Grade Melatonin Products Average Selling Price (ASP), 2020-2031

7 Sights by Source
7.1 Pharmaceutical Grade Melatonin Products Classification by Source
7.1.1 Natural Melatonin
7.1.2 Synthetic Melatonin
7.2 by Source, Global Pharmaceutical Grade Melatonin Products Consumption Value & CAGR, 2020 VS 2024 VS 2031
7.3 by Source, Global Pharmaceutical Grade Melatonin Products Consumption Value, 2020-2031
7.4 by Source, Global Pharmaceutical Grade Melatonin Products Sales Quantity, 2020-2031
7.5 by Source, Global Pharmaceutical Grade Melatonin Products Average Selling Price (ASP), 2020-2031

8 Sights by Dosage Forms
8.1 Pharmaceutical Grade Melatonin Products Classification by Dosage Forms
8.1.1 Immediate-Release Tablets
8.1.2 Sustained-Release Tablets
8.2 by Dosage Forms, Global Pharmaceutical Grade Melatonin Products Consumption Value & CAGR, 2020 VS 2024 VS 2031
8.3 by Dosage Forms, Global Pharmaceutical Grade Melatonin Products Consumption Value, 2020-2031
8.4 by Dosage Forms, Global Pharmaceutical Grade Melatonin Products Sales Quantity, 2020-2031
8.5 by Dosage Forms, Global Pharmaceutical Grade Melatonin Products Average Selling Price (ASP), 2020-2031

9 Sights by Application
9.1 Pharmaceutical Grade Melatonin Products Segment by Application
9.1.1 Hospital and Clinic
9.1.2 Pharmacy
9.1.3 Other
9.2 by Application, Global Pharmaceutical Grade Melatonin Products Consumption Value & CAGR, 2020 VS 2024 VS 2031
9.3 by Application, Global Pharmaceutical Grade Melatonin Products Consumption Value, 2020-2031
9.4 by Application, Global Pharmaceutical Grade Melatonin Products Sales Quantity, 2020-2031
9.5 by Application, Global Pharmaceutical Grade Melatonin Products Price, 2020-2031

10 Sales Sights by Region
10.1 By Region, Global Pharmaceutical Grade Melatonin Products Consumption Value, 2020 VS 2024 VS 2031
10.2 By Region, Global Pharmaceutical Grade Melatonin Products Consumption Value, 2020-2031
10.3 By Region, Global Pharmaceutical Grade Melatonin Products Sales Quantity, 2020-2031
10.4 North America
10.4.1 North America Pharmaceutical Grade Melatonin Products Market Size & Forecasts, 2020-2031
10.4.2 By Country, North America Pharmaceutical Grade Melatonin Products Market Size Market Share
10.5 Europe
10.5.1 Europe Pharmaceutical Grade Melatonin Products Market Size & Forecasts, 2020-2031
10.5.2 By Country, Europe Pharmaceutical Grade Melatonin Products Market Size Market Share
10.6 Asia Pacific
10.6.1 Asia Pacific Pharmaceutical Grade Melatonin Products Market Size & Forecasts, 2020-2031
10.6.2 By Country/Region, Asia Pacific Pharmaceutical Grade Melatonin Products Market Size Market Share
10.7 South America
10.7.1 South America Pharmaceutical Grade Melatonin Products Market Size & Forecasts, 2020-2031
10.7.2 By Country, South America Pharmaceutical Grade Melatonin Products Market Size Market Share
10.8 Middle East & Africa

11 Sales Sights by Country Level
11.1 By Country, Global Pharmaceutical Grade Melatonin Products Market Size & CAGR, 2020 VS 2024 VS 2031
11.2 By Country, Global Pharmaceutical Grade Melatonin Products Consumption Value, 2020-2031
11.3 By Country, Global Pharmaceutical Grade Melatonin Products Sales Quantity, 2020-2031
11.4 United States
11.4.1 United States Pharmaceutical Grade Melatonin Products Market Size, 2020-2031
11.4.2 by Type, United States Pharmaceutical Grade Melatonin Products Sales Quantity Market Share, 2024 VS 2031
11.4.3 by Application, United States Pharmaceutical Grade Melatonin Products Sales Quantity Market Share, 2024 VS 2031
11.5 Europe
11.5.1 Europe Pharmaceutical Grade Melatonin Products Market Size, 2020-2031
11.5.2 by Type, Europe Pharmaceutical Grade Melatonin Products Sales Quantity Market Share, 2024 VS 2031
11.5.3 by Application, Europe Pharmaceutical Grade Melatonin Products Sales Quantity Market Share, 2024 VS 2031
11.6 China
11.6.1 China Pharmaceutical Grade Melatonin Products Market Size, 2020-2031
11.6.2 by Type, China Pharmaceutical Grade Melatonin Products Sales Quantity Market Share, 2024 VS 2031
11.6.3 by Application, China Pharmaceutical Grade Melatonin Products Sales Quantity Market Share, 2024 VS 2031
11.7 Japan
11.7.1 Japan Pharmaceutical Grade Melatonin Products Market Size, 2020-2031
11.7.2 by Type, Japan Pharmaceutical Grade Melatonin Products Sales Quantity Market Share, 2024 VS 2031
11.7.3 by Application, Japan Pharmaceutical Grade Melatonin Products Sales Quantity Market Share, 2024 VS 2031
11.8 South Korea
11.8.1 South Korea Pharmaceutical Grade Melatonin Products Market Size, 2020-2031
11.8.2 by Type, South Korea Pharmaceutical Grade Melatonin Products Sales Quantity Market Share, 2024 VS 2031
11.8.3 by Application, South Korea Pharmaceutical Grade Melatonin Products Sales Quantity Market Share, 2024 VS 2031
11.9 Southeast Asia
11.9.1 Southeast Asia Pharmaceutical Grade Melatonin Products Market Size, 2020-2031
11.9.2 by Type, Southeast Asia Pharmaceutical Grade Melatonin Products Sales Quantity Market Share, 2024 VS 2031
11.9.3 by Application, Southeast Asia Pharmaceutical Grade Melatonin Products Sales Quantity Market Share, 2024 VS 2031
11.10 India
11.10.1 India Pharmaceutical Grade Melatonin Products Market Size, 2020-2031
11.10.2 by Type, India Pharmaceutical Grade Melatonin Products Sales Quantity Market Share, 2024 VS 2031
11.10.3 by Application, India Pharmaceutical Grade Melatonin Products Sales Quantity Market Share, 2024 VS 2031
11.11 Middle East & Africa
11.11.1 Middle East & Africa Pharmaceutical Grade Melatonin Products Market Size, 2020-2031
11.11.2 by Type, Middle East & Africa Pharmaceutical Grade Melatonin Products Sales Quantity Market Share, 2024 VS 2031
11.11.3 by Application, Middle East & Africa Pharmaceutical Grade Melatonin Products Sales Quantity Market Share, 2024 VS 2031

12 Manufacturers Profile
12.1 Natrol
12.1.1 Natrol Company Information, Head Office, Market Area, and Industry Position
12.1.2 Natrol Pharmaceutical Grade Melatonin Products Models, Specifications, and Application
12.1.3 Natrol Pharmaceutical Grade Melatonin Products Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.1.4 Natrol Company Profile and Main Business
12.1.5 Natrol Recent Developments
12.2 Pharmavite
12.2.1 Pharmavite Company Information, Head Office, Market Area, and Industry Position
12.2.2 Pharmavite Pharmaceutical Grade Melatonin Products Models, Specifications, and Application
12.2.3 Pharmavite Pharmaceutical Grade Melatonin Products Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.2.4 Pharmavite Company Profile and Main Business
12.2.5 Pharmavite Recent Developments
12.3 Nature's Bounty
12.3.1 Nature's Bounty Company Information, Head Office, Market Area, and Industry Position
12.3.2 Nature's Bounty Pharmaceutical Grade Melatonin Products Models, Specifications, and Application
12.3.3 Nature's Bounty Pharmaceutical Grade Melatonin Products Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.3.4 Nature's Bounty Company Profile and Main Business
12.3.5 Nature's Bounty Recent Developments
12.4 Jameison
12.4.1 Jameison Company Information, Head Office, Market Area, and Industry Position
12.4.2 Jameison Pharmaceutical Grade Melatonin Products Models, Specifications, and Application
12.4.3 Jameison Pharmaceutical Grade Melatonin Products Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.4.4 Jameison Company Profile and Main Business
12.4.5 Jameison Recent Developments
12.5 Rexall Sundown
12.5.1 Rexall Sundown Company Information, Head Office, Market Area, and Industry Position
12.5.2 Rexall Sundown Pharmaceutical Grade Melatonin Products Models, Specifications, and Application
12.5.3 Rexall Sundown Pharmaceutical Grade Melatonin Products Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.5.4 Rexall Sundown Company Profile and Main Business
12.5.5 Rexall Sundown Recent Developments
12.6 GNC
12.6.1 GNC Company Information, Head Office, Market Area, and Industry Position
12.6.2 GNC Pharmaceutical Grade Melatonin Products Models, Specifications, and Application
12.6.3 GNC Pharmaceutical Grade Melatonin Products Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.6.4 GNC Company Profile and Main Business
12.6.5 GNC Recent Developments
12.7 Church & Dwight
12.7.1 Church & Dwight Company Information, Head Office, Market Area, and Industry Position
12.7.2 Church & Dwight Pharmaceutical Grade Melatonin Products Models, Specifications, and Application
12.7.3 Church & Dwight Pharmaceutical Grade Melatonin Products Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.7.4 Church & Dwight Company Profile and Main Business
12.7.5 Church & Dwight Recent Developments
12.8 Pfizer
12.8.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
12.8.2 Pfizer Pharmaceutical Grade Melatonin Products Models, Specifications, and Application
12.8.3 Pfizer Pharmaceutical Grade Melatonin Products Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.8.4 Pfizer Company Profile and Main Business
12.8.5 Pfizer Recent Developments
12.9 Solgar
12.9.1 Solgar Company Information, Head Office, Market Area, and Industry Position
12.9.2 Solgar Pharmaceutical Grade Melatonin Products Models, Specifications, and Application
12.9.3 Solgar Pharmaceutical Grade Melatonin Products Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.9.4 Solgar Company Profile and Main Business
12.9.5 Solgar Recent Developments
12.10 Biotics Research
12.10.1 Biotics Research Company Information, Head Office, Market Area, and Industry Position
12.10.2 Biotics Research Pharmaceutical Grade Melatonin Products Models, Specifications, and Application
12.10.3 Biotics Research Pharmaceutical Grade Melatonin Products Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.10.4 Biotics Research Company Profile and Main Business
12.10.5 Biotics Research Recent Developments
12.11 Now Food
12.11.1 Now Food Company Information, Head Office, Market Area, and Industry Position
12.11.2 Now Food Pharmaceutical Grade Melatonin Products Models, Specifications, and Application
12.11.3 Now Food Pharmaceutical Grade Melatonin Products Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.11.4 Now Food Company Profile and Main Business
12.11.5 Now Food Recent Developments
12.12 Neurim Pharmaceuticals
12.12.1 Neurim Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
12.12.2 Neurim Pharmaceuticals Pharmaceutical Grade Melatonin Products Models, Specifications, and Application
12.12.3 Neurim Pharmaceuticals Pharmaceutical Grade Melatonin Products Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.12.4 Neurim Pharmaceuticals Company Profile and Main Business
12.12.5 Neurim Pharmaceuticals Recent Developments
12.13 Slenyto
12.13.1 Slenyto Company Information, Head Office, Market Area, and Industry Position
12.13.2 Slenyto Pharmaceutical Grade Melatonin Products Models, Specifications, and Application
12.13.3 Slenyto Pharmaceutical Grade Melatonin Products Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.13.4 Slenyto Company Profile and Main Business
12.13.5 Slenyto Recent Developments
12.14 Nature Made
12.14.1 Nature Made Company Information, Head Office, Market Area, and Industry Position
12.14.2 Nature Made Pharmaceutical Grade Melatonin Products Models, Specifications, and Application
12.14.3 Nature Made Pharmaceutical Grade Melatonin Products Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.14.4 Nature Made Company Profile and Main Business
12.14.5 Nature Made Recent Developments
12.15 Centrum
12.15.1 Centrum Company Information, Head Office, Market Area, and Industry Position
12.15.2 Centrum Pharmaceutical Grade Melatonin Products Models, Specifications, and Application
12.15.3 Centrum Pharmaceutical Grade Melatonin Products Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.15.4 Centrum Company Profile and Main Business
12.15.5 Centrum Recent Developments
12.16 Vitafusion
12.16.1 Vitafusion Company Information, Head Office, Market Area, and Industry Position
12.16.2 Vitafusion Pharmaceutical Grade Melatonin Products Models, Specifications, and Application
12.16.3 Vitafusion Pharmaceutical Grade Melatonin Products Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.16.4 Vitafusion Company Profile and Main Business
12.16.5 Vitafusion Recent Developments
12.17 CVS Health
12.17.1 CVS Health Company Information, Head Office, Market Area, and Industry Position
12.17.2 CVS Health Pharmaceutical Grade Melatonin Products Models, Specifications, and Application
12.17.3 CVS Health Pharmaceutical Grade Melatonin Products Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.17.4 CVS Health Company Profile and Main Business
12.17.5 CVS Health Recent Developments
12.18 Leosons Corporation
12.18.1 Leosons Corporation Company Information, Head Office, Market Area, and Industry Position
12.18.2 Leosons Corporation Pharmaceutical Grade Melatonin Products Models, Specifications, and Application
12.18.3 Leosons Corporation Pharmaceutical Grade Melatonin Products Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.18.4 Leosons Corporation Company Profile and Main Business
12.18.5 Leosons Corporation Recent Developments
12.19 Zahler
12.19.1 Zahler Company Information, Head Office, Market Area, and Industry Position
12.19.2 Zahler Pharmaceutical Grade Melatonin Products Models, Specifications, and Application
12.19.3 Zahler Pharmaceutical Grade Melatonin Products Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.19.4 Zahler Company Profile and Main Business
12.19.5 Zahler Recent Developments
12.20 Mauricettes
12.20.1 Mauricettes Company Information, Head Office, Market Area, and Industry Position
12.20.2 Mauricettes Pharmaceutical Grade Melatonin Products Models, Specifications, and Application
12.20.3 Mauricettes Pharmaceutical Grade Melatonin Products Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.20.4 Mauricettes Company Profile and Main Business
12.20.5 Mauricettes Recent Developments
12.21 AGB-Pharma
12.21.1 AGB-Pharma Company Information, Head Office, Market Area, and Industry Position
12.21.2 AGB-Pharma Pharmaceutical Grade Melatonin Products Models, Specifications, and Application
12.21.3 AGB-Pharma Pharmaceutical Grade Melatonin Products Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.21.4 AGB-Pharma Company Profile and Main Business
12.21.5 AGB-Pharma Recent Developments
12.22 Alturix
12.22.1 Alturix Company Information, Head Office, Market Area, and Industry Position
12.22.2 Alturix Pharmaceutical Grade Melatonin Products Models, Specifications, and Application
12.22.3 Alturix Pharmaceutical Grade Melatonin Products Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.22.4 Alturix Company Profile and Main Business
12.22.5 Alturix Recent Developments
12.23 Pharma Nord
12.23.1 Pharma Nord Company Information, Head Office, Market Area, and Industry Position
12.23.2 Pharma Nord Pharmaceutical Grade Melatonin Products Models, Specifications, and Application
12.23.3 Pharma Nord Pharmaceutical Grade Melatonin Products Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.23.4 Pharma Nord Company Profile and Main Business
12.23.5 Pharma Nord Recent Developments
12.24 Teva
12.24.1 Teva Company Information, Head Office, Market Area, and Industry Position
12.24.2 Teva Pharmaceutical Grade Melatonin Products Models, Specifications, and Application
12.24.3 Teva Pharmaceutical Grade Melatonin Products Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.24.4 Teva Company Profile and Main Business
12.24.5 Teva Recent Developments
12.25 Mylan
12.25.1 Mylan Company Information, Head Office, Market Area, and Industry Position
12.25.2 Mylan Pharmaceutical Grade Melatonin Products Models, Specifications, and Application
12.25.3 Mylan Pharmaceutical Grade Melatonin Products Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.25.4 Mylan Company Profile and Main Business
12.25.5 Mylan Recent Developments
12.26 Xiu Zheng
12.26.1 Xiu Zheng Company Information, Head Office, Market Area, and Industry Position
12.26.2 Xiu Zheng Pharmaceutical Grade Melatonin Products Models, Specifications, and Application
12.26.3 Xiu Zheng Pharmaceutical Grade Melatonin Products Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.26.4 Xiu Zheng Company Profile and Main Business
12.26.5 Xiu Zheng Recent Developments
12.27 By-Health
12.27.1 By-Health Company Information, Head Office, Market Area, and Industry Position
12.27.2 By-Health Pharmaceutical Grade Melatonin Products Models, Specifications, and Application
12.27.3 By-Health Pharmaceutical Grade Melatonin Products Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.27.4 By-Health Company Profile and Main Business
12.27.5 By-Health Recent Developments
12.28 Conba Pharm
12.28.1 Conba Pharm Company Information, Head Office, Market Area, and Industry Position
12.28.2 Conba Pharm Pharmaceutical Grade Melatonin Products Models, Specifications, and Application
12.28.3 Conba Pharm Pharmaceutical Grade Melatonin Products Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.28.4 Conba Pharm Company Profile and Main Business
12.28.5 Conba Pharm Recent Developments
12.29 Meiaojian Biotechnology
12.29.1 Meiaojian Biotechnology Company Information, Head Office, Market Area, and Industry Position
12.29.2 Meiaojian Biotechnology Pharmaceutical Grade Melatonin Products Models, Specifications, and Application
12.29.3 Meiaojian Biotechnology Pharmaceutical Grade Melatonin Products Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.29.4 Meiaojian Biotechnology Company Profile and Main Business
12.29.5 Meiaojian Biotechnology Recent Developments

13 Conclusion

14 Appendix
14.1 Research Methodology
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Market Estimation Model
14.4 Disclaimer

According to YH Research, the global market for Pharmaceutical Grade Melatonin Products should grow from US$ 1188 million in 2024 to US$ 1827 million by 2031, with a CAGR of 6.3% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Pharmaceutical Grade Melatonin Products

According to YH Research, the global market for Pharmaceutical Grade Melatonin Products should grow from US$ 1188 million in 2024 to US$ 1827 million by 2031, with a CAGR of 6.3% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

In 2024, global Pharmaceutical Grade Melatonin Products production reached approximately 55.85 million units , with an average global market price of around US$ 20 per unit.

Pharmaceutical-grade melatonin products are prescription drugs or high-standard pharmaceutical preparations made from melatonin raw materials produced in accordance with pharmaceutical standards (such as USP, EP, BP, etc.) and GMP regulations. These include sustained-release tablets, immediate-release tablets, microcapsules, oral liquids, sprays, and hospital-prepared formulations, used to treat or assist in the treatment of insomnia, circadian rhythm disorders, sleep disorders in the elderly, and insomnia related to autism spectrum disorder (ASD) and neurogenetic diseases in some children. Representative products include Neurim/Aspen's sustained-release tablets Circadin and children's sustained-release tablets Slenyto, as well as various generic or branded melatonin preparations marketed by companies such as Aspen Pharmacare, AGB-Pharma, Alturix, Pharma Nord, Teva, and Mylan. Compared to ordinary food-grade or dietary supplements, pharmaceutical-grade products adhere to stricter drug regulatory requirements regarding raw material purity, impurity profile control, dissolution and sustained-release profiles, bioequivalence, stability testing, and evidence of clinical efficacy and safety. They are often dispensed as prescription drugs in hospitals, pharmacies, or after online consultations with doctors/pharmacies.

From an industry chain perspective, the upstream of pharmaceutical-grade melatonin products mainly consists of melatonin API and excipient suppliers that meet USP/EP/BP standards, including Swati Spentose, Biophore India, and Laurus Labs in India, and Huanggang Saikang (Nutrakey system) and Sichuan Benepure in China. These suppliers provide pharmaceutical-grade melatonin and excipients with a purity of 98–99.9% through pharmacopoeia standards, DMF/ASMF, EU-WC, and other systems. The midstream is handled by pharmaceutical companies specializing in neuroscience and sleep, such as Neurim Pharmaceuticals, AGB-Pharma, Alturix, Teva, and Mylan, which develop formulations and manufacture pharmaceutical products, forming extended-release tablets, pediatric formulations, and generic drugs for various countries. The downstream is provided to end patients through hospital prescriptions, community pharmacies, public health insurance catalogs, and compliant online consultation platforms for the treatment of chronic insomnia in the elderly, ASD/NGD-related insomnia in children, and jet lag syndrome. Some high-standard dietary supplement brands also use pharmaceutical-grade melatonin. APIs are sold to physicians and functional medicine clinics. Overall, the high degree of specialization and international certification requirements on the raw material side, the sustained-release technology and pediatric-specific dosage form development on the formulation side, and the regulatory and reimbursement policies of various countries downstream, together determine the positioning and profit model of pharmaceutical-grade melatonin products between "pharmaceuticals" and "high-end nutritional products".

The annual production capacity of a single-line Pharmaceutical Grade Melatonin Products is approximately 500k units, with a gross profit margin of approximately 55%-70%.

Overall, pharmaceutical grade melatonin products occupy a niche, higher-end position between conventional hypnotic drugs and over-the-counter melatonin supplements, combining physician-led, evidence-based use with growing public awareness of sleep health. Thanks to a more favourable profile in terms of dependence, safety and tolerability during long-term use, prolonged-release melatonin has gradually been incorporated into clinical guidelines and expert recommendations in many countries for older adults with chronic insomnia, patients with circadian rhythm disorders and children with neurodevelopmental conditions associated with sleep difficulties, creating a relatively stable base of prescription demand. On the supply side, originator products and a small group of companies with strong modified-release and pediatric-formulation capabilities still enjoy notable barriers to entry in several markets, but as patents and data-exclusivity periods expire, generic competitors are entering, intensifying price competition while also broadening the range of dosage forms and dosing strategies available. Regionally, some European and Commonwealth countries are leveraging prescription and reimbursement channels to drive uptake, North America shows a mix of prescription use and high-standard OTC positioning, and emerging markets are gradually opening as regulatory frameworks become clearer. In summary, pharmaceutical grade melatonin products are likely to sustain growth that outpaces traditional hypnotics but is somewhat more measured than that of the broader melatonin supplement category, functioning primarily as relatively safe, long-term sleep and circadian-management tools within medical channels, clearly differentiated in branding and regulation from ordinary melatonin nutraceuticals.

This report studies and analyses global Pharmaceutical Grade Melatonin Products status and future trends, helps the client to determine the Pharmaceutical Grade Melatonin Products market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Pharmaceutical Grade Melatonin Products, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2024 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Pharmaceutical Grade Melatonin Products market size, history data 2020-2025, and forecast data 2026-2031, (US$ million) & (K Units)
(2) Global Pharmaceutical Grade Melatonin Products sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (K Units)
(3) China Pharmaceutical Grade Melatonin Products sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (K Units)
(4) Global Pharmaceutical Grade Melatonin Products key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Pharmaceutical Grade Melatonin Products key producing regions, capacity, production, and year over year growth
(6) Pharmaceutical Grade Melatonin Products industry chains, upstream, midstream and downstream
Market segment by players, this report covers
    Natrol
    Pharmavite
    Nature's Bounty
    Jameison
    Rexall Sundown
    GNC
    Church & Dwight
    Pfizer
    Solgar
    Biotics Research
    Now Food
    Neurim Pharmaceuticals
    Slenyto
    Nature Made
    Centrum
    Vitafusion
    CVS Health
    Leosons Corporation
    Zahler
    Mauricettes
    AGB-Pharma
    Alturix
    Pharma Nord
    Teva
    Mylan
    Xiu Zheng
    By-Health
    Conba Pharm
    Meiaojian Biotechnology

Market segment by Type, covers
    Tablets
    Oral Solution

Market segment by Source, covers
    Natural Melatonin
    Synthetic Melatonin

Market segment by Dosage Forms, covers
    Immediate-Release Tablets
    Sustained-Release Tablets

Market segment by Application, can be divided into
    Hospital and Clinic
    Pharmacy
    Other

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Pharmaceutical Grade Melatonin Products product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Pharmaceutical Grade Melatonin Products market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 3: China Pharmaceutical Grade Melatonin Products market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 4: Global key producing regions of Pharmaceutical Grade Melatonin Products, percent & CAGR, 2020-2031
Chapter 5: Pharmaceutical Grade Melatonin Products industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.